Florence De Fraipont

Grenoble, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Journal: The Lancet regional health. Europe

Published: July 30, 2026

Metabolic Profiling of Circulating and Tumour-Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients.

Metabolic Profiling of Circulating and Tumour-Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients.

Journal: Immunology

Published: March 19, 2026

Melanoma causes phenotypic modulations and metabolic switches of iNKT cells influencing clinical outcomes.

Melanoma causes phenotypic modulations and metabolic switches of iNKT cells influencing clinical outcomes.

Journal: Frontiers in immunology

Published: September 11, 2025

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Journal: The Lancet regional health. Europe

Published: July 07, 2025

Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.

Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.

Journal: Clinical genetics

Published: January 16, 2025

BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study.

BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study.

Journal: Clinical epigenetics

Published: November 25, 2024

PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling.

PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling.

Journal: Life science alliance

Published: June 06, 2024

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma.

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma.

Journal: Nature communications

Published: October 20, 2023

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.

Journal: ESMO open

Published: April 13, 2023

The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.

The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.

Journal: Frontiers in immunology

Published: December 09, 2022

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.

Journal: Frontiers in immunology

Published: September 09, 2022

Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer.

Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer.

Journal: Molecular oncology

Published: November 18, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026